Japanese biotechnology startup PorMedTec is moving closer to bringing pig-to-human kidney transplants into clinical practice, with plans to launch the country’s first human trials in 2028 and seek conditional regulatory approval the following year. The Kanagawa-based company said it expects the initial clinical studies to be conducted at Hokkaido University Hospital and Shonan Kamakura General Hospital, marking Japan’s first clinical …
Read More »
The Market Monitor Minding the Nation's Business